Surveillance and management of multidrug-resistant microorganisms (Q37912231)

25 August 2017

1 reference

title

Surveillance and management of multidrug-resistant microorganisms (English)

1 reference

25 August 2017

main subject

multiple drug resistance

1 reference

2

1 reference

25 August 2017

3

Mario Venditti

1 reference

25 August 2017

author name string

Giovanni Battista Orsi

series ordinal

1

1 reference

25 August 2017

publication date

1 August 2011

1 reference

Expert Review of Anti-infective Therapy

25 August 2017

published in

1 reference

25 August 2017

volume

9

1 reference

25 August 2017

issue

8

1 reference

25 August 2017

page(s)

653-679

1 reference

25 August 2017

1 reference

Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents.

21 January 2018

1 reference

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

21 January 2018

1 reference

Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

21 January 2018

1 reference

National hospital infection surveillance on methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Staphylococcus aureus bacteremia, Australia

21 January 2018

1 reference

International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009.

21 January 2018

1 reference

Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

21 January 2018

1 reference

Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004.

21 January 2018

1 reference

Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.

21 January 2018

1 reference

Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe

21 January 2018

1 reference

Current challenges in treating MRSA: what are the options?

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus disease in three communities

21 January 2018

1 reference

Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA).

21 January 2018

1 reference

Community-associated MRSA in the United Kingdom

21 January 2018

1 reference

Community-associated methicillin-resistant Staphylococcus aureus, Switzerland

21 January 2018

1 reference

Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe

21 January 2018

1 reference

Emergence of a new clone carrying Panton-Valentine leukocidin genes and staphylococcal cassette chromosome mec type V among methicillin-resistant Staphylococcus aureus in Greece

21 January 2018

1 reference

Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections

21 January 2018

1 reference

Emergence of SCCmec type IV and SCCmec type V methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leukocidin genes in a large academic teaching hospital in central Switzerland: external invaders or persisting circulators?

21 January 2018

1 reference

Health care-associated and community-associated methicillin-resistant Staphylococcus aureus infections: A comparison of definitions

21 January 2018

1 reference

Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea

21 January 2018

1 reference

Health economic issues in the treatment of drug-resistant serious Gram-positive infections

21 January 2018

1 reference

Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature

21 January 2018

1 reference

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges

21 January 2018

1 reference

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection

21 January 2018

1 reference

Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study

21 January 2018

1 reference

Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000.

21 January 2018

1 reference

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

21 January 2018

1 reference

Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

21 January 2018

1 reference

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

21 January 2018

1 reference

The risk of infection after nasal colonization with Staphylococcus aureus

21 January 2018

1 reference

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

21 January 2018

1 reference

Pneumonia caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Treatment options for nosocomial pneumonia due to MRSA.

21 January 2018

1 reference

Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia

21 January 2018

1 reference

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes

21 January 2018

1 reference

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

21 January 2018

1 reference

Community associated methicillin resistant staphylococcus aureus (CA-MRSA) infective endocarditis in Italy

21 January 2018

1 reference

Contemporary clinical profile and outcome of prosthetic valve endocarditis.

21 January 2018

1 reference

Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis

21 January 2018

1 reference

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

21 January 2018

1 reference

Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus

21 January 2018

1 reference

Serious infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: recognition and prevention in intensive care units

21 January 2018

1 reference

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

21 January 2018

1 reference

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus

21 January 2018

1 reference

Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.

21 January 2018

1 reference

Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?

21 January 2018

1 reference

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin

21 January 2018

1 reference

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus

21 January 2018

1 reference

Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).

21 January 2018

1 reference

Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

21 January 2018

1 reference

Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?

21 January 2018

1 reference

DNA methylase modifications and other linezolid resistance mutations in coagulase-negative staphylococci in Italy.

21 January 2018

1 reference

Whole-Genome Sequencing of Staphylococcus haemolyticus Uncovers the Extreme Plasticity of Its Genome and the Evolution of Human-Colonizing Staphylococcal Species

21 January 2018

1 reference

Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.

21 January 2018

1 reference

Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?

21 January 2018

1 reference

Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus

21 January 2018

1 reference

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections

21 January 2018

1 reference

Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus necrotizing pneumonia

21 January 2018

1 reference

Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication

21 January 2018

1 reference

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

21 January 2018

1 reference

Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica

21 January 2018

1 reference

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children

21 January 2018

1 reference

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

21 January 2018

1 reference

Telavancin: a novel lipoglycopeptide

21 January 2018

1 reference

New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin

21 January 2018

1 reference

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens

21 January 2018

1 reference

Successful Treatment of Vancomycin-Intermediate Staphylococcus aureus Pacemaker Lead Infective Endocarditis with Telavancin

21 January 2018

1 reference

Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin

21 January 2018

1 reference

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

21 January 2018

1 reference

Ceftaroline fosamil: a novel broad-spectrum cephalosporin

21 January 2018

1 reference

Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults

21 January 2018

1 reference

Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections

21 January 2018

1 reference

The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008).

21 January 2018

1 reference

Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding

21 January 2018

1 reference

Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan.

21 January 2018

1 reference

Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection

21 January 2018

1 reference

ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries

21 January 2018

1 reference

The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics

21 January 2018

1 reference

Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr

21 January 2018

1 reference

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States

21 January 2018

1 reference

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus

21 January 2018

1 reference

IS21-558 insertion sequences are involved in the mobility of the multiresistance gene cfr.

21 January 2018

1 reference

Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain.

21 January 2018

1 reference

Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.

21 January 2018

1 reference

Vancomycin-resistant enterococci: colonization, infection, detection, and treatment

21 January 2018

1 reference

In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate.

21 January 2018

1 reference

Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci

21 January 2018

1 reference

Health and economic outcomes of vancomycin-resistant enterococci

21 January 2018

1 reference

The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients

21 January 2018

1 reference

Emergence and management of drug-resistant enterococcal infections

21 January 2018

1 reference

Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006.

21 January 2018

1 reference

The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004.

21 January 2018

1 reference

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis

21 January 2018

1 reference

Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

21 January 2018

1 reference

Effect of Nosocomial Vancomycin-Resistant Enterococcal Bacteremia on Mortality, Length of Stay, and Costs

21 January 2018

1 reference

A prospective study of the impact of colonization following hospital admission by glycopeptide-resistant Enterococci on mortality during a hospital outbreak

21 January 2018

1 reference

Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci

21 January 2018

1 reference

Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis

21 January 2018

1 reference

A potential role for daptomycin in enterococcal infections: what is the evidence?

21 January 2018

1 reference

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

21 January 2018

1 reference

Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens

21 January 2018

1 reference

CTX-M: changing the face of ESBLs in Europe

21 January 2018

1 reference

Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure

21 January 2018

1 reference

An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant

21 January 2018

1 reference

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

21 January 2018

1 reference

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

21 January 2018

1 reference

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

21 January 2018

1 reference

Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome

21 January 2018

1 reference

Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?

21 January 2018

1 reference

Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.

21 January 2018

1 reference

Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin

21 January 2018

1 reference

KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea

21 January 2018

1 reference

Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin

21 January 2018

1 reference

ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline

21 January 2018

1 reference

Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes

21 January 2018

1 reference

Acinetobacter: an old friend, but a new enemy

21 January 2018

1 reference

Treatment of Pseudomonas aeruginosa infection in critically ill patients

21 January 2018

1 reference

Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum

21 January 2018

1 reference

The clinical consequences of antimicrobial resistance

21 January 2018

1 reference

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production

21 January 2018

1 reference

Acinetobacter baumannii: a universal threat to public health?

21 January 2018

1 reference

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

21 January 2018

1 reference

The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants

21 January 2018

1 reference

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa

21 January 2018

1 reference

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

21 January 2018

1 reference

Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.

21 January 2018

1 reference

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

21 January 2018

1 reference

Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial

21 January 2018

1 reference

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.

21 January 2018

1 reference

AcinetobacterOutbreaks, 1977–2000

21 January 2018

1 reference

How long do nosocomial pathogens persist on inanimate surfaces? A systematic review

21 January 2018

1 reference

The epidemiology and control of Acinetobacter baumannii in health care facilities

21 January 2018

1 reference

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

21 January 2018

1 reference

Global challenge of multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

21 January 2018

1 reference

Acinetobacter baumannii: an emerging multidrug-resistant threat

21 January 2018

1 reference

Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature

21 January 2018

1 reference

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

21 January 2018

1 reference

Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact

21 January 2018

1 reference

Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.

21 January 2018

1 reference

Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit

21 January 2018

1 reference

Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.

21 January 2018

1 reference

Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence

21 January 2018

1 reference

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review

21 January 2018

1 reference

Acinetobacter baumannii: emergence of a successful pathogen

21 January 2018

1 reference

Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies

21 January 2018

1 reference

Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit

21 January 2018

1 reference

Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia

21 January 2018

1 reference

Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia

21 January 2018

1 reference

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

21 January 2018

1 reference

Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies

21 January 2018

1 reference

Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

21 January 2018

1 reference

Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study

21 January 2018

1 reference

Fosfomycin: an old, new friend?

21 January 2018

1 reference

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

21 January 2018

1 reference

Hospital-acquired infections due to gram-negative bacteria

21 January 2018

1 reference

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues

21 January 2018

1 reference

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

21 January 2018

1 reference

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.

21 January 2018

1 reference

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.

21 January 2018

1 reference

Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

21 January 2018

1 reference

21 January 2018

1 reference

Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration

21 January 2018

1 reference

Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria

21 January 2018

1 reference

Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.

21 January 2018

1 reference

Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature

21 January 2018

1 reference

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

21 January 2018

1 reference

Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens

21 January 2018

1 reference

Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials

21 January 2018

1 reference

Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease

21 January 2018

1 reference

Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis

21 January 2018

1 reference

Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint

21 January 2018

1 reference

Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options

21 January 2018

1 reference

Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution

21 January 2018

1 reference

Tigecycline treatment of critically ill patients: the LatinUser experience.

21 January 2018

1 reference

Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin

21 January 2018

1 reference

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

21 January 2018

1 reference

Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections

21 January 2018

1 reference

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

21 January 2018

1 reference

Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.

21 January 2018

1 reference

Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection

21 January 2018

1 reference

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin

21 January 2018

1 reference

Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials

21 January 2018

1 reference

Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria

21 January 2018

1 reference

Extracellular concentrations of fosfomycin in lung tissue of septic patients

21 January 2018

1 reference

Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation

21 January 2018

1 reference

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review

21 January 2018

1 reference

Antimicrobial therapy for Stenotrophomonas maltophilia infections

21 January 2018

1 reference

Management of multidrug-resistant organisms in health care settings, 2006.

21 January 2018

1 reference

Screening and isolation for infection control

21 January 2018

1 reference

Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy.

21 January 2018

1 reference

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus

21 January 2018

1 reference

High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies

21 January 2018

1 reference

Control of vancomycin-resistant enterococcus in health care facilities in a region.

21 January 2018

1 reference

Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units

21 January 2018

1 reference

Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a Veterans Affairs Medical Center

21 January 2018

1 reference

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.

21 January 2018

1 reference

The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review

21 January 2018

1 reference

Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment

21 January 2018

1 reference

Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature

21 January 2018

1 reference

Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus?

21 January 2018

1 reference

Look before you leap: active surveillance for multidrug-resistant organisms

21 January 2018

1 reference

Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy

21 January 2018

1 reference

Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations

21 January 2018

1 reference

Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients

21 January 2018

1 reference

Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis

21 January 2018

1 reference

Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens

21 January 2018

1 reference

Antibiotic control of antibiotic resistance in hospitals: a simulation study

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization

21 January 2018

1 reference

Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients

21 January 2018

1 reference

Isolation Precautions for Methicillin-Resistant Staphylococcus aureus: Electronic Surveillance to Monitor Adherence

21 January 2018

1 reference

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

21 January 2018

1 reference

Reduction of health care associated infection risk in neonates by successful hand hygiene promotion

21 January 2018

1 reference

Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

21 January 2018

1 reference

Videos in clinical medicine. Hand hygiene

21 January 2018

1 reference

'My five moments for hand hygiene': a user-centred design approach to understand, train, monitor and report hand hygiene

21 January 2018

1 reference

Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature

21 January 2018

1 reference

Infection prevention research in Europe: recent advances and future priorities

21 January 2018

1 reference

Transfer of vancomycin-resistant enterococci via health care worker hands

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus survival on hospital fomites.

21 January 2018

1 reference

Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system

21 January 2018

1 reference

Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus: source control and surveillance organization

21 January 2018

1 reference

Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit.

21 January 2018

1 reference

Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.

21 January 2018

1 reference

Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci

21 January 2018

1 reference

Health-care workers: source, vector, or victim of MRSA?

21 January 2018

1 reference

The value of routine screening of staff for MRSA.

21 January 2018

1 reference

The role of environmental cleaning in the control of hospital-acquired infection

21 January 2018

1 reference

Contamination of hospital curtains with healthcare-associated pathogens

21 January 2018

1 reference

A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients' acquisition of MRSA.

21 January 2018

1 reference

Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit

21 January 2018

1 reference

Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment

21 January 2018

1 reference

Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis.

21 January 2018

1 reference

Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates.

21 January 2018

1 reference

Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use.

21 January 2018

1 reference

The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studies.

21 January 2018

1 reference

Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study.

21 January 2018

1 reference

Hospital-based strategies for combating resistance

21 January 2018

1 reference

Design of a 'day 3 bundle' to improve the reassessment of inpatient empirical antibiotic prescriptions

21 January 2018

1 reference

Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system.

21 January 2018

1 reference

Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms

21 January 2018

1 reference

Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals

21 January 2018

1 reference

Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?

21 January 2018

1 reference

Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals.

21 January 2018

1 reference

Antimicrobial stewardship: bridging the gap between quality care and cost

21 January 2018

1 reference

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

21 January 2018

1 reference

Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. a

21 January 2018

1 reference

Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients

21 January 2018

1 reference

Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization

21 January 2018

1 reference

Real-Time Polymerase Chain Reaction Detection of Methicillin-Resistant Staphylococcus aureus: Impact on Nosocomial Transmission and Costs

21 January 2018

1 reference

Lack of community-associated MRSA in Rome

21 January 2018

1 reference

Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007–2009 study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.11.77

1 reference

25 August 2017

1 reference